MBXBF
Price
$0.19
Change
+$0.01 (+5.56%)
Updated
Sep 22 closing price
Capitalization
26.96M
MMIRF
Price
$0.09
Change
+$0.04 (+80.00%)
Updated
Sep 16 closing price
Capitalization
40.73M
Interact to see
Advertisement

MBXBF vs MMIRF

Header iconMBXBF vs MMIRF Comparison
Open Charts MBXBF vs MMIRFBanner chart's image
Microbix Biosystems
Price$0.19
Change+$0.01 (+5.56%)
Volume$6K
Capitalization26.96M
Medmira
Price$0.09
Change+$0.04 (+80.00%)
Volume$500
Capitalization40.73M
MBXBF vs MMIRF Comparison Chart in %
Loading...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBXBF vs. MMIRF commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBXBF is a Buy and MMIRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (MBXBF: $0.19 vs. MMIRF: $0.09)
Brand notoriety: MBXBF and MMIRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBXBF: 5% vs. MMIRF: 6%
Market capitalization -- MBXBF: $26.96M vs. MMIRF: $40.73M
MBXBF [@Biotechnology] is valued at $26.96M. MMIRF’s [@Biotechnology] market capitalization is $40.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBXBF’s FA Score shows that 1 FA rating(s) are green whileMMIRF’s FA Score has 0 green FA rating(s).

  • MBXBF’s FA Score: 1 green, 4 red.
  • MMIRF’s FA Score: 0 green, 5 red.
According to our system of comparison, MMIRF is a better buy in the long-term than MBXBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBXBF’s TA Score shows that 2 TA indicator(s) are bullish while MMIRF’s TA Score has 4 bullish TA indicator(s).

  • MBXBF’s TA Score: 2 bullish, 5 bearish.
  • MMIRF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MMIRF is a better buy in the short-term than MBXBF.

Price Growth

MBXBF (@Biotechnology) experienced а +14.32% price change this week, while MMIRF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MMIRF($40.7M) has a higher market cap than MBXBF($27M). MMIRF YTD gains are higher at: 587.023 vs. MBXBF (-34.256). MBXBF has higher annual earnings (EBITDA): 2.47M vs. MMIRF (-3.24M). MBXBF has more cash in the bank: 12.1M vs. MMIRF (18.3K). MBXBF has less debt than MMIRF: MBXBF (6.41M) vs MMIRF (10.2M). MBXBF has higher revenues than MMIRF: MBXBF (21.1M) vs MMIRF (254K).
MBXBFMMIRFMBXBF / MMIRF
Capitalization27M40.7M66%
EBITDA2.47M-3.24M-76%
Gain YTD-34.256587.023-6%
P/E Ratio22.25N/A-
Revenue21.1M254K8,307%
Total Cash12.1M18.3K66,120%
Total Debt6.41M10.2M63%
FUNDAMENTALS RATINGS
MBXBF vs MMIRF: Fundamental Ratings
MBXBF
MMIRF
OUTLOOK RATING
1..100
1196
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
6334
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (36) in the null industry is somewhat better than the same rating for MBXBF (73). This means that MMIRF’s stock grew somewhat faster than MBXBF’s over the last 12 months.

MMIRF's Profit vs Risk Rating (100) in the null industry is in the same range as MBXBF (100). This means that MMIRF’s stock grew similarly to MBXBF’s over the last 12 months.

MBXBF's SMR Rating (92) in the null industry is in the same range as MMIRF (100). This means that MBXBF’s stock grew similarly to MMIRF’s over the last 12 months.

MMIRF's Price Growth Rating (34) in the null industry is in the same range as MBXBF (63). This means that MMIRF’s stock grew similarly to MBXBF’s over the last 12 months.

MBXBF's P/E Growth Rating (8) in the null industry is significantly better than the same rating for MMIRF (100). This means that MBXBF’s stock grew significantly faster than MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBXBFMMIRF
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 23 days ago
72%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBLOF0.95N/A
N/A
Public Bank Ltd
MDTWF2.15N/A
N/A
Mediterranean Towers LTD
PMMCF0.22-0.01
-3.51%
Andina Copper Corporation
XISHY8.42-0.35
-3.96%
Xinyi Solar Holdings Limited
CRTD0.25-0.02
-7.44%
CREATD INC.

MBXBF and

Correlation & Price change

A.I.dvisor tells us that MBXBF and CMND have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CMND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
N/A
CMND - MBXBF
25%
Poorly correlated
-7.27%
BVNRY - MBXBF
20%
Poorly correlated
-0.12%
MMIRF - MBXBF
15%
Poorly correlated
N/A
IVEVF - MBXBF
8%
Poorly correlated
N/A
IVBXF - MBXBF
7%
Poorly correlated
-3.20%
More

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and SGMT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and SGMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
SGMT - MMIRF
32%
Poorly correlated
-1.17%
NWPHF - MMIRF
29%
Poorly correlated
N/A
VTYX - MMIRF
26%
Poorly correlated
-1.06%
AXSM - MMIRF
21%
Poorly correlated
+0.60%
DNTH - MMIRF
21%
Poorly correlated
+0.29%
More